AstraZeneca has announced positive results from its Bax24 trial of baxdrostat, an investigational treatment for hypertension, ...
Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...
The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed ...
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, ...
Cross-functional collaboration is often portrayed as a way to drive innovation. But when done well, another aspect of its ...
Merck (known as MSD outside the US and Canada) has entered into a funding agreement with Blackstone Life Sciences to support ...
As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies can ...
Genentech, a member of the Roche Group, has announced positive results from the first of two phase 3 trials investigating ...
LEO Pharma has received Technology Appraisal Guidance (TAG) from the National Institute for Health and Care Excellence (NICE) ...
In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever ...
The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer ...
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback